Skip to main content
Livermore
Livermore
ZHEN

DDFG, Inc

SEC CIK
0001967640
Latest filing
Jul 28, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by DDFG, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q2 2026)
10,728
Value
$874.4K
% of portfolio
0.2%
Quarters held
15
Since Q4 2022
Holdings of ARWR by DDFG, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,728$874.4K0.2%00.0%UnchangedHolders
Q1 202610,728$672.6K0.1%−4,000−27.2%ReducedHolders
Q4 202514,728$977.8K0.2%00.0%UnchangedHolders
Q3 202514,728$508.0K0.1%00.0%UnchangedHolders
Q2 202514,728$232.7K0.1%00.0%UnchangedHolders
Q1 202514,728$187.6K0.1%00.0%UnchangedHolders
Q4 202414,728$276.9K0.1%00.0%UnchangedHolders
Q3 202414,728$285.3K0.1%00.0%UnchangedHolders
Q2 202414,728$382.8K0.1%00.0%UnchangedHolders
Q1 202414,728$421.2K0.1%00.0%UnchangedHolders
Q4 202314,728$450.7K0.2%00.0%UnchangedHolders
Q3 202314,728$395.7K0.1%00.0%UnchangedHolders
Q2 202314,728$525.2K0.2%00.0%UnchangedHolders
Q1 202314,728$374.1K0.1%00.0%UnchangedHolders
Q4 202214,728$597.4K0.2%–No prior filingHolders